Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPhoenix Group Holdings Regulatory News (PHNX)

  • There is currently no data for PHNX

Response to FCA Statement

28 Mar 2014 16:43

RNS Number : 5058D
Phoenix Group Holdings
28 March 2014
 



 

Phoenix Group Holdings ("Phoenix") response to FCA statement

 

 

Phoenix notes the statement issued by the FCA earlier today regarding a thematic review into the fair treatment of longstanding or legacy customers within closed life funds.

 

Although little detail has been provided regarding the scope and nature of any review, Phoenix makes the following observations:

 

· The FCA has stated that the review will not consider the suitability of historic advice, nor will it require a review of individual policies.

· The review will look at the level of servicing provided to policyholders whose policies are managed within closed life funds. Phoenix welcomes this review as we continue to look for areas where we can deliver better levels of customer service. We have achieved significant policy administration migrations to newer and better systems resulting in improved customer service. We regularly review our full product set to ensure it is operating as intended and remain committed to maintaining our focus on the governance of our products.

· Phoenix does not write new products (other than vesting annuities) and therefore we do not believe that any review of cross-subsidisation (in particular of the cost of new products) would be relevant to Phoenix.

· Furthermore, should the review look at the charging structures on historic policies, we are confident that our historic charging structures, including exit charges, have been compliant and in accordance with our commitments to our policyholders.

 

The press speculation regarding the thematic review follows two previous issues which have impacted the life assurance market over the last two weeks:

 

· The first of these issues was the announcement by the Chancellor in the Budget last week that policyholders would no longer be required to convert their pensions into an annuity on retirement. As explained in our full year results announcement, issued on Wednesday 26 March, we believe that this change will not have a material impact on Phoenix.

· Yesterday the Government announced a cap for all workplace pension schemes for auto enrolment. It is estimated that the cost of applying the cap to our schemes could have a maximum impact on our MCEV of £40 million.

 

In response to the statement from the FCA, Clive Bannister (Phoenix CEO) commented:

 

"Policyholders are central to everything that we do at Phoenix and we remain focussed on improving our performance and service. We aim to treat our policyholders fairly at all times. Operationally, we continue to streamline and modernise the business for the benefit of our policyholders. For example, in 2013 we increased the distributable estate by £565 million, with around 115,000 policyholders benefiting from £157 million of estate distributed in that year.

 

As our recent full-year results amply demonstrate, Phoenix is performing extremely well. This week we announced our highest ever cash generation (£817 million) and MCEV of £2.4 billion. We remain confident in the outlook for the Group.

 

We note that the review will not apply "current standards retrospectively" but is designed to "assess whether there is an issue that requires any action".

 

We will of course co-operate fully with any review conducted by the FCA."

 

We will update the market when we have greater clarity on the scope and nature of the review.

 

 

 

 

Enquiries

 

Investors / analysts

Sam Perowne

Head of Investor Relations, Phoenix Group

+44 (0)20 3735 0021

 

Media

Neil Bennett, Peter Ogden, Tom Eckersley,

Maitland

+44 (0)20 7379 5151

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRQKFDNABKDFNB
Date   Source Headline
31st Jan 20222:00 pmRNSTotal Voting Rights
28th Jan 20227:09 amRNSStrategic Investor Update
18th Jan 20226:00 pmRNSHolding(s) in Company
18th Jan 20226:00 pmRNSHolding(s) in Company
17th Jan 20221:00 pmRNSDirector/PDMR Shareholding
14th Jan 20225:00 pmRNSHolding(s) in Company
12th Jan 20227:00 amRNSResult of Secondary Placing in Phoenix Group Hldgs
11th Jan 20225:09 pmRNSProposed Secondary Placing in Phoenix Group Hldgs
11th Jan 20227:00 amRNS2021 Bulk Purchase Annuity Transactions
7th Jan 20222:30 pmRNSDirector/PDMR Shareholding
31st Dec 202112:00 pmRNSTotal Voting Rights
30th Dec 20214:30 pmRNSDirector/PDMR Shareholding
22nd Dec 202112:00 pmRNSChange of Auditor
20th Dec 20211:00 pmRNSBlock listing Interim Review
10th Dec 20214:00 pmRNSDirector/PDMR Shareholding
30th Nov 20212:15 pmRNSTotal Voting Rights
9th Nov 202110:15 amRNSDirector/PDMR Shareholding
1st Nov 20214:52 pmRNSArk Life Assurance Sale Completion
29th Oct 20214:30 pmRNSTotal Voting Rights
8th Oct 20219:30 amRNSDirector/PDMR Shareholding
30th Sep 20215:00 pmRNSTotal Voting Rights
27th Sep 202111:00 amRNSDirector/PDMR Shareholding
14th Sep 20212:07 pmRNSInternal Model Harmonisation Approval
8th Sep 20214:15 pmRNSDirector/PDMR Shareholding
8th Sep 20214:15 pmRNSDirector/PDMR Shareholding
1st Sep 202110:00 amRNSTotal Voting Rights
25th Aug 202112:00 pmRNSDirector/PDMR Shareholding
20th Aug 202111:45 amRNSDirector/PDMR Shareholding
20th Aug 202111:45 amRNSDirector/PDMR Shareholding
16th Aug 202112:00 pmRNSDirector/PDMR Shareholding
12th Aug 20214:00 pmRNSDirector/PDMR Shareholding
11th Aug 20217:00 amRNS2021 Half Year Results
9th Aug 20214:30 pmRNSDirector/PDMR Shareholding
30th Jul 202111:45 amRNSTotal Voting Rights
13th Jul 20217:00 amRNSSale of Ark Life Assurance Company
8th Jul 20214:20 pmRNSDirector/PDMR Shareholding
1st Jul 20214:00 pmRNSTotal Voting Rights
29th Jun 20214:15 pmRNSHolding(s) in Company
25th Jun 20214:00 pmRNSDirector/PDMR Shareholding
24th Jun 20215:15 pmRNSBlock listing Interim Review
23rd Jun 20215:30 pmRNSPhoenix Group Holdings
23rd Jun 20217:00 amRNSResult of Secondary Placing in Phoenix Group Hldgs
23rd Jun 20217:00 amRNSStrategic Investor Update and Board Change
22nd Jun 20214:40 pmRNSProposed Secondary Placing in Phoenix Group Hldgs
16th Jun 20213:00 pmRNSBlock Listing Application
15th Jun 202112:00 pmRNSDiscussions in Respect of Sale Discontinued
9th Jun 20218:30 amRNSDirector/PDMR Shareholding
28th May 20212:00 pmRNSTotal Voting Rights
20th May 20214:00 pmRNSDirector/PDMR Shareholding
18th May 20217:00 amRNSStatement in Response to Press Speculation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.